Deutsche Bank Ag\ Acelrx Pharmaceuticals Inc Transaction History

Deutsche Bank Ag\

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$0.93 - $1.51 $5,781 - $9,387	-6,217 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$1.03 - $1.7 $65,709 - $108,453	-63,796 Reduced 91.12%	6,217 $9,000
Q1 2021 May 13, 2021	BUY	$1.25 - $2.77 $8,007 - $17,744	6,406 Added 10.07%	70,013 $119,000
Q4 2020 Feb 16, 2021	BUY	$1.18 - $1.98 $19,964 - $33,499	16,919 Added 36.24%	63,607 $79,000
Q3 2020 Nov 12, 2020	BUY	$1.01 - $1.81 $9,397 - $16,840	9,304 Added 24.89%	46,688 $67,000
Q2 2020 Aug 13, 2020	BUY	$1.03 - $1.69 $12,805 - $21,011	12,433 Added 49.83%	37,384 $46,000
Q1 2020 May 14, 2020	SELL	$0.76 - $2.07 $1,206 - $3,287	-1,588 Reduced 5.98%	24,951 $30,000
Q4 2019 Feb 14, 2020	BUY	$1.66 - $2.4 $10,424 - $15,072	6,280 Added 31.0%	26,539 $55,000
Q3 2019 Nov 14, 2019	SELL	$2.1 - $2.87 $75,963 - $103,816	-36,173 Reduced 64.1%	20,259 $44,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $117,280 - $219,482	55,848 Added 9563.01%	56,432 $141,000
Q1 2019 May 15, 2019	BUY	$2.35 - $3.83 $1,372 - $2,236	584 New	584 $1,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $4.6 $46,997 - $83,149	-18,076 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.13 - $4.2 $38,312 - $75,545	17,987 Added 20210.11%	18,076 $61,000
Q4 2017 Feb 14, 2018	SELL	$1.75 - $5.5 $220,806 - $693,962	-126,175 Reduced 99.93%	89 $0
Q3 2017 Nov 14, 2017	BUY	$2.9 - $4.6 $366,165 - $580,814	126,264	126,264 $580,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.